CompletedNot Applicable

Injection Therapy for Neuropathic Pain

China36 participantsStarted 2023-06-01

Plain-language summary

Shoulder, neck, back and temporal pain and herpes zoster pain are neuropathic pain. Preliminary clinical studies have confirmed that injection of freshly prepared HA35 can relieve neuropathic pain. This clinical study is a prospective repeated experiments. The purpose of this study was to verify the effectiveness of HA35 injection therapy.

Who can participate

Age range18 Years – 60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * The course of neck, back and temporal pain ranged from 0 to 8 months. * The course of herpes zoster of 0-2 months. * Adults aged 18-60 years. * Be willing and capable of giving informed consent. * Have a clinical diagnosis of neuropathic pain as determined by a multidisciplinary study team. * Subject must sign the informed consent in person prior to beginning any screening procedure. Exclusion Criteria: * Have a persistent pain resulted from other medical conditions or unknown causes. * Pregnant females. * Be concomitantly participating in another clinical study. * Have been immunocompromised.

What they're measuring

the Numerical Pain Rating Scale (NPRS) scores

Timeframe: 30 min to 3 hours

the General Comfort Questionnaire (GCQ) scores

Timeframe: 24 hours

Trial details

NCT IDNCT05809700

SponsorDove Medical Press Ltd

Sponsor typeNETWORK

Study typeINTERVENTIONAL

Primary completion2023-07-12

View on ClinicalTrials.gov More Neuropathic Pain trials